Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance.
- NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_assertion wasGeneratedBy ECO_0000203 NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance.
- NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_assertion wasDerivedFrom befree-20140225 NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance.
- NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_assertion SIO_000772 22525818 NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance.
- NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_assertion evidence source_evidence_literature NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance.
- NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_assertion description "[AGTR1 immunoreactivity was found in six of ten (60.0%) normal endometrium, 11 of 14 (78.6%) endometrial hyperplasia, and 27 of 62 (43.5%) endometrial carcinoma tissues (P=0.051), and patients with AGTR1 expression showed trend towards improved survival after multivariate analysis (P=0.08).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance.
- befree-20140225 importedOn "2014-02-25" NP631334.RARtKTy1tsVcVtLlKSdxABzO6fBrwT6sKhKCVOnrJb_10130_provenance.